What is LifeMD, Inc.'s market cap?

LifeMD, Inc. (LFMD) has a market capitalization of $187.2M and trades on NASDAQ.

What is LifeMD, Inc.'s revenue and profitability?

LifeMD, Inc. generated $180.1M in trailing twelve-month revenue with net income of $5.7M, representing a net margin of 3.1%. Gross margin stands at 86.1%, with free cash flow of $12.0M. These figures are based on the Q1 2026 filing.

Who are LifeMD, Inc.'s competitors?

LifeMD, Inc.'s key competitors include Hims & Hers Health, Inc., CVS Health, Teladoc Health, Inc., and others. These companies compete in similar markets and product categories.

Who does LifeMD, Inc. partner with?

LifeMD, Inc.'s notable partners include Eli Lilly and Company, Novo Nordisk, Medifast, Inc., and others.

What subsidiaries does LifeMD, Inc. have?

LifeMD, Inc.'s subsidiaries include LifeMD Pharmacy Services, LLC, LifeMD PC, Cleared Technologies, PBC.

Where is LifeMD, Inc. headquartered?

LifeMD, Inc. is headquartered in United States of America and employs approximately 232 people. It has been publicly traded since 1995.

LifeMD, Inc.

LFMD

LifeMD is a patient-centric, direct-to-patient healthcare company that provides virtual medical care and pharmacy services through a vertically integrated platform.

Market cap

$187.16M-59.2%

Revenue$180.1M+12.3%

Net income$5.7M+134%

Free cash flow$12.0M-42.2%

EPS (diluted)$0.07+115%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$50.2MBeat by $1.3M EPS-$0.20Miss by $0.06

Read the full report

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$49.2M

EPS estimate-$0.15

Financials

Q1 2026

Income statement

See full

Revenue$50.2M-1.4%

Gross profit$44.2M+3.5%

Operating income-$8.9M-656%

Net income-$8.9M-4,728%

EPS (diluted)-$0.20-900%

Balance sheet

See full

Cash & equivalents$34.5M+7.9%

Total debt$6.2M-76.9%

Total equity$15.0M+746%

Total assets$70.1M-4.7%

Cash flow

See full

Operating cash flow$444.6K-85.5%

CapEx$105.2K-10.5%

Free cash flow$339.4K-88.5%

Valuation & ratios

Valuation

See full

Market cap$187.16M-59.2%

Enterprise value$158.86M-67.7%

P/E33×—

P/S1×-1.8×

Profitability

See full

Gross margin86.1%+0.9pp

Operating margin-9.8%-0.9pp

Net margin3.1%+1.8pp

Returns & leverage

See full

Debt / equity0.4×—

Current ratio1×+0.2×

Segments

By segment

See full

Telehealth$50.2M-1.4%

Telehealth Subscription Revenue$30.4M+0.9%

Competitors

By market cap

CVS Health$136.61B+81.1%

Hims & Hers Health$7.0B-46.7%

Hinge Health, Inc.$5.8B+64.4%

LifeStance Health Group$4.2B+156%

Teladoc Health$1.6B+11.8%

LifeMD, Inc.$187.2M-62.1%

EUDA Health Holdings$56.9M-53.6%

VSee Health, Inc.$3.8M-81.9%

By revenue growth

Hinge Health, Inc.+49.8%

Hims & Hers Health+32.8%

LifeStance Health Group+16.5%

LifeMD, Inc.+12.3%

CVS Health+7.6%

Teladoc Health-1.5%

By net margin

LifeMD, Inc.3.15%+13.5pp

LifeStance Health Group1.55%+3.8pp

CVS Health0.719%-0.7pp

Hims & Hers Health-0.559%-9.8pp

Teladoc Health-6.81%+32.8pp

Hinge Health, Inc.-83.91%-78.8pp

Profile

LifeMD is a patient-centric, direct-to-patient healthcare company that provides virtual medical care and pharmacy services through a vertically integrated platform. The company combines proprietary technology, an affiliated 50-state medical group, and pharmacy infrastructure to deliver longitudinal care for primary care and specialty areas. Its core value proposition focuses on providing a convenient, cost-effective alternative to traditional in-person healthcare models.

Competitive position

LifeMD maintains a market-leading position through a vertically integrated model that controls the technology, clinical provider network, and pharmacy fulfillment ecosystem.

GeographiesUnited States

Customer segmentsRetail consumers, Medicare beneficiaries, Pharmaceutical manufacturers

Business modelSubscription, Direct-to-consumer, B2B Partnerships

SuppliersPharmaceutical manufacturers, Cloud infrastructure providers, Diagnostic laboratory partners, Third-party logistics and shipping providers

CustomersIndividual patient subscribers, Commercial health insurance payors, Government health programs (Medicare), B2B healthcare product companies

CountryUnited States of America

Listed1995

Employees232.0

CEOJustin Schreiber

SectorHealthcare

IndustryMedical - Pharmaceuticals

Websitelifemd.com

FilingsSEC EDGAR

Ask your AI about LifeMD, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LifeMD, Inc.'s market cap?: LifeMD, Inc. (LFMD) has a market capitalization of $187.2M and trades on NASDAQ.
What is LifeMD, Inc.'s revenue and profitability?: LifeMD, Inc. generated $180.1M in trailing twelve-month revenue with net income of $5.7M, representing a net margin of 3.1%. Gross margin stands at 86.1%, with free cash flow of $12.0M. These figures are based on the Q1 2026 filing.
Who are LifeMD, Inc.'s competitors?: LifeMD, Inc.'s key competitors include Hims & Hers Health, Inc., CVS Health, Teladoc Health, Inc., and others. These companies compete in similar markets and product categories.
Who does LifeMD, Inc. partner with?: LifeMD, Inc.'s notable partners include Eli Lilly and Company, Novo Nordisk, Medifast, Inc., and others.
What subsidiaries does LifeMD, Inc. have?: LifeMD, Inc.'s subsidiaries include LifeMD Pharmacy Services, LLC, LifeMD PC, Cleared Technologies, PBC.
Where is LifeMD, Inc. headquartered?: LifeMD, Inc. is headquartered in United States of America and employs approximately 232 people. It has been publicly traded since 1995.